The Lancet Diabetes & Endocrinology Commission on type 1 diabetes: looking back to move forward

Type 1 diabetes care has evolved significantly since the discovery of insulin in 1921, improving life expectancy, particularly in high-income countries. However, global disparities in access to insulin and care persist, especially in low- and middle-income countries, where limited resources result in poorer outcomes. Despite global initiatives like the WHO’s Global Diabetes Compact, a comprehensive, person-centered approach for type 1 diabetes is still lacking. This article examines these challenges and introduces a new Lancet Diabetes & Endocrinology Commission aimed at developing a global plan to improve equitable care and quality of life for people with type 1 diabetes worldwide.